Avance takes valuation a step further. Our combination of financial and industry expertise along with a broad experience will ensure your success in licensing, M&A, investing, and strategic decision taking.
Deal Terms in Alzheimer's Disease 2000 - 2014
Report by Avance on deal terms and sales assumptions of Alzheimer Deals.
Article in Les Nouvelles
How to determine fair license terms
Survey on Discount Rates in Biotech
What discount rates do professionals use in the biotech industry?
3rd Edition of "Valuation in Life Sciences"
The industry reference book, completely revised and extended.